This inventor holds 2 USPTO granted patents and 1 published patent application. Top assignee: Novozymes A/s. Active years: 2024-2026.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2024-2026
Title: Innovations by Jeffrey Schultchen in Probiotic Supplements
Introduction
Jeffrey Schultchen is an accomplished inventor based in Berlin, Germany. He has made significant contributions to the field of metabolic health through his innovative probiotic supplements. With a total of 2 patents, Schultchen's work focuses on improving the well-being of mammalian subjects.
Latest Patents
Schultchen's latest patents include a probiotic supplement designed to enhance metabolic health. The application discloses strains that have a beneficial effect on the metabolic health of a mammalian subject. Furthermore, it details compositions comprising such strains and their use for improving metabolic health or lowering blood glucose levels in a mammalian subject.
Career Highlights
Jeffrey Schultchen is currently associated with Novozymes A/S, a company known for its commitment to innovation in biotechnology. His work at Novozymes has allowed him to explore the potential of probiotics in enhancing metabolic health.
Collaborations
Some of his notable coworkers include Teis Jensen and Nanna Ny Kristensen, who have collaborated with him on various projects related to probiotic research.
Conclusion
Jeffrey Schultchen's contributions to the field of probiotics and metabolic health highlight the importance of innovation in improving health outcomes. His patents reflect a commitment to advancing scientific knowledge and practical applications in this vital area.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile